
Surgepays fell 93.8% from $2.43 to $0.15, behind the S&P 500's +11.2%. Its worst day was Jan 21 (−35.8%), and its low came Oct 19 at $0.12.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.38 missed the $-0.15 estimate on $18.7M revenue (est. $18.1M).
−17.5% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
Surgepays shares fell 35.8%, while the S&P 500 rose 1.2%.
−35.8%, the year's worst day · S&P 500 +1.2%
EPS of $-0.69 missed the $-0.09 estimate on $16.2M revenue (est. $25.4M).
−33.6% · S&P 500 +0.8%
EPS of $-0.51 missed the $-0.15 estimate on $16.0M revenue (est. $19.3M).
−6.9% · S&P 500 −1.2%
Surgepays shares rose 38.1%, while the S&P 500 fell 0.1%.
+38.1% · S&P 500 −0.1%
Surgepays shares rose 45.5%, while the S&P 500 fell 0.2%.
+45.5%, the year's best day · S&P 500 −0.2%
EPS of $0.05 beat the $-0.11 estimate on $16.2M revenue (est. $13.8M).
+14.4%, on 291M shares, the year's heaviest volume · S&P 500 −0.2%
Surgepays closed at its lowest level of the year, 95.2% below where the year started.
−5.3% · S&P 500 +0.4%
Where it ended: a close of $0.15 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.07, revenue est. $16.5M).
Nothing in the past 12 months.
All SURG dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SURG and SPY from Benzinga historical bars. Not investment advice.